Salveen Richter
Stock Analyst at Goldman Sachs
(3.49)
# 950
Out of 5,113 analysts
206
Total ratings
44.35%
Success rate
7.04%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | Maintains: Neutral | $40 → $25 | $28.67 | -12.80% | 10 | Nov 20, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $9 → $11 | $14.29 | -23.02% | 3 | Nov 5, 2025 | |
| QURE uniQure | Maintains: Neutral | $56 → $38 | $24.37 | +55.93% | 9 | Nov 4, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $14 → $16 | $22.99 | -30.40% | 4 | Oct 30, 2025 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $45 → $65 | $82.14 | -20.87% | 5 | Sep 26, 2025 | |
| APLS Apellis Pharmaceuticals | Downgrades: Sell | $26 → $18 | $21.81 | -17.47% | 9 | Sep 26, 2025 | |
| IMNM Immunome | Initiates: Buy | $26 | $25.70 | +1.17% | 1 | Sep 22, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $504 → $566 | $354.75 | +59.55% | 6 | Sep 16, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $44 → $38 | $8.49 | +347.59% | 6 | Aug 12, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Neutral | $10 → $19 | $22.17 | -14.30% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $15 → $17 | $26.20 | -35.11% | 9 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $26.18 | +41.33% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $47 | $54.26 | -13.38% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $124 → $104 | $56.85 | +82.94% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $41 | $15.90 | +157.86% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $19.23 | -48.00% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $771.25 | +4.25% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $174.12 | +13.14% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $8.50 | +111.76% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $140.97 | -31.90% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $45.45 | +12.21% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $21.25 | +88.24% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $14.83 | -19.08% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $82 → $72 | $117.52 | -38.73% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $103.47 | -32.35% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $24.62 | +208.69% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $351.32 | -0.38% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $474.17 | +17.89% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $25.99 | -80.76% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.53 | +1,926.14% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $268.09 | -16.07% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $4.28 | +414.02% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $25.28 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.13 | +626.39% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $4.60 | +95.65% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $4.76 | -36.97% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $4.97 | +20.72% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $69.45 | -38.08% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $4.23 | -52.72% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $5.56 | +1,698.56% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $12.60 | +4,661.90% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $120.81 | -58.61% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $66.91 | -32.75% | 1 | Mar 17, 2020 |
Agios Pharmaceuticals
Nov 20, 2025
Maintains: Neutral
Price Target: $40 → $25
Current: $28.67
Upside: -12.80%
Amicus Therapeutics
Nov 5, 2025
Maintains: Neutral
Price Target: $9 → $11
Current: $14.29
Upside: -23.02%
uniQure
Nov 4, 2025
Maintains: Neutral
Price Target: $56 → $38
Current: $24.37
Upside: +55.93%
Arcus Biosciences
Oct 30, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $22.99
Upside: -30.40%
Ionis Pharmaceuticals
Sep 26, 2025
Upgrades: Neutral
Price Target: $45 → $65
Current: $82.14
Upside: -20.87%
Apellis Pharmaceuticals
Sep 26, 2025
Downgrades: Sell
Price Target: $26 → $18
Current: $21.81
Upside: -17.47%
Immunome
Sep 22, 2025
Initiates: Buy
Price Target: $26
Current: $25.70
Upside: +1.17%
Alnylam Pharmaceuticals
Sep 16, 2025
Maintains: Buy
Price Target: $504 → $566
Current: $354.75
Upside: +59.55%
4D Molecular Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $8.49
Upside: +347.59%
Sarepta Therapeutics
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $22.17
Upside: -14.30%
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $26.20
Upside: -35.11%
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $26.18
Upside: +41.33%
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $54.26
Upside: -13.38%
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $56.85
Upside: +82.94%
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $15.90
Upside: +157.86%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $19.23
Upside: -48.00%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $771.25
Upside: +4.25%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $174.12
Upside: +13.14%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $8.50
Upside: +111.76%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $140.97
Upside: -31.90%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $45.45
Upside: +12.21%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $21.25
Upside: +88.24%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $14.83
Upside: -19.08%
Jan 13, 2025
Maintains: Neutral
Price Target: $82 → $72
Current: $117.52
Upside: -38.73%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $103.47
Upside: -32.35%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $24.62
Upside: +208.69%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $351.32
Upside: -0.38%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $474.17
Upside: +17.89%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $25.99
Upside: -80.76%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.53
Upside: +1,926.14%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $268.09
Upside: -16.07%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $4.28
Upside: +414.02%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $25.28
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.13
Upside: +626.39%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $4.60
Upside: +95.65%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $4.76
Upside: -36.97%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $4.97
Upside: +20.72%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $69.45
Upside: -38.08%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $4.23
Upside: -52.72%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $5.56
Upside: +1,698.56%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $12.60
Upside: +4,661.90%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $120.81
Upside: -58.61%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $66.91
Upside: -32.75%